LUPIN
Back to Cashflow Statement
|
LUPIN Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹1,732 Cr | ₹-2,184 Cr | ₹-337 Cr | ₹-1,572 Cr | ₹-1,885 Cr |
What is the latest Cash Flow from Financing Activities ratio of LUPIN ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹1,732 Cr |
Mar2024 | ₹-2,184 Cr |
Mar2023 | ₹-337 Cr |
Mar2022 | ₹-1,572 Cr |
Mar2021 | ₹-1,885 Cr |
How is Cash Flow from Financing Activities of LUPIN Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹1,732 Cr | Positive | |
Mar2024 | ₹-2,184 Cr | Negative | |
Mar2023 | ₹-337 Cr | Negative | |
Mar2022 | ₹-1,572 Cr | Negative | |
Mar2021 | ₹-1,885 Cr | - |
Compare Cash Flow from Financing Activities of peers of LUPIN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LUPIN | ₹88,530.1 Cr | 0.4% | -0.1% | -10.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,838.0 Cr | 4% | 4.5% | -14.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,653.0 Cr | 2.3% | -5.1% | 8.2% | Stock Analytics | |
CIPLA | ₹122,276.0 Cr | 1.7% | -4.1% | -8.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,310.0 Cr | -1.7% | -2% | 4.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,202.0 Cr | 1.1% | -0.4% | -7.5% | Stock Analytics |
LUPIN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LUPIN | 0.4% |
-0.1% |
-10.1% |
SENSEX | 1.7% |
1.5% |
-3% |
You may also like the below Video Courses